vs

Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and TELOS CORP (TLS). Click either name above to swap in a different company.

TELOS CORP is the larger business by last-quarter revenue ($46.8M vs $31.1M, roughly 1.5× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -34.9%, a 2.8% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs -4.5%). TELOS CORP produced more free cash flow last quarter ($8.0M vs $25.0K). Over the past eight quarters, TELOS CORP's revenue compounded faster (25.7% CAGR vs -0.1%).

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.

LFCR vs TLS — Head-to-Head

Bigger by revenue
TLS
TLS
1.5× larger
TLS
$46.8M
$31.1M
LFCR
Growing faster (revenue YoY)
TLS
TLS
+81.8% gap
TLS
77.4%
-4.5%
LFCR
Higher net margin
LFCR
LFCR
2.8% more per $
LFCR
-32.1%
-34.9%
TLS
More free cash flow
TLS
TLS
$7.9M more FCF
TLS
$8.0M
$25.0K
LFCR
Faster 2-yr revenue CAGR
TLS
TLS
Annualised
TLS
25.7%
-0.1%
LFCR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
LFCR
LFCR
TLS
TLS
Revenue
$31.1M
$46.8M
Net Profit
$-10.0M
$-16.3M
Gross Margin
25.0%
35.0%
Operating Margin
-9.9%
-39.6%
Net Margin
-32.1%
-34.9%
Revenue YoY
-4.5%
77.4%
Net Profit YoY
-52.0%
-74.8%
EPS (diluted)
$-0.29
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFCR
LFCR
TLS
TLS
Q4 25
$46.8M
Q3 25
$31.1M
$51.4M
Q2 25
$36.0M
Q1 25
$35.2M
$30.6M
Q4 24
$32.6M
$26.4M
Q3 24
$24.7M
$23.8M
Q2 24
$28.5M
Q1 24
$35.7M
$29.6M
Net Profit
LFCR
LFCR
TLS
TLS
Q4 25
$-16.3M
Q3 25
$-10.0M
$-2.1M
Q2 25
$-9.5M
Q1 25
$-14.8M
$-8.6M
Q4 24
$-6.6M
$-9.3M
Q3 24
$-16.2M
$-28.1M
Q2 24
$-7.8M
Q1 24
$15.6M
$-7.4M
Gross Margin
LFCR
LFCR
TLS
TLS
Q4 25
35.0%
Q3 25
25.0%
39.9%
Q2 25
33.2%
Q1 25
28.0%
39.8%
Q4 24
34.0%
40.3%
Q3 24
21.8%
13.2%
Q2 24
34.1%
Q1 24
33.3%
37.0%
Operating Margin
LFCR
LFCR
TLS
TLS
Q4 25
-39.6%
Q3 25
-9.9%
-4.8%
Q2 25
-27.5%
Q1 25
-25.7%
-29.5%
Q4 24
-6.0%
-37.6%
Q3 24
-46.9%
-121.4%
Q2 24
-30.3%
Q1 24
-2.5%
-28.5%
Net Margin
LFCR
LFCR
TLS
TLS
Q4 25
-34.9%
Q3 25
-32.1%
-4.1%
Q2 25
-26.5%
Q1 25
-42.0%
-28.1%
Q4 24
-20.2%
-35.4%
Q3 24
-65.7%
-118.0%
Q2 24
-27.2%
Q1 24
43.8%
-24.9%
EPS (diluted)
LFCR
LFCR
TLS
TLS
Q4 25
$-0.22
Q3 25
$-0.29
$-0.03
Q2 25
$-0.13
Q1 25
$-0.47
$-0.12
Q4 24
$-0.25
$-0.13
Q3 24
$-0.53
$-0.39
Q2 24
$-0.11
Q1 24
$0.42
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFCR
LFCR
TLS
TLS
Cash + ST InvestmentsLiquidity on hand
$18.9M
$53.2M
Total DebtLower is stronger
$136.0M
Stockholders' EquityBook value
$-10.5M
$96.0M
Total Assets
$235.2M
$139.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFCR
LFCR
TLS
TLS
Q4 25
$53.2M
Q3 25
$18.9M
$59.0M
Q2 25
$57.0M
Q1 25
$5.4M
$57.8M
Q4 24
$9.5M
$54.6M
Q3 24
$69.8M
Q2 24
$80.1M
Q1 24
$93.9M
Total Debt
LFCR
LFCR
TLS
TLS
Q4 25
Q3 25
$136.0M
Q2 25
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q2 24
Q1 24
$97.1M
Stockholders' Equity
LFCR
LFCR
TLS
TLS
Q4 25
$96.0M
Q3 25
$-10.5M
$119.7M
Q2 25
$118.4M
Q1 25
$2.2M
$126.1M
Q4 24
$15.4M
$127.1M
Q3 24
$-3.9M
$129.5M
Q2 24
$149.1M
Q1 24
$17.7M
$154.4M
Total Assets
LFCR
LFCR
TLS
TLS
Q4 25
$139.9M
Q3 25
$235.2M
$164.3M
Q2 25
$165.0M
Q1 25
$237.7M
$158.1M
Q4 24
$255.4M
$158.2M
Q3 24
$246.8M
$166.3M
Q2 24
$182.4M
Q1 24
$246.2M
$195.4M
Debt / Equity
LFCR
LFCR
TLS
TLS
Q4 25
Q3 25
Q2 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q2 24
Q1 24
5.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFCR
LFCR
TLS
TLS
Operating Cash FlowLast quarter
$1.8M
$8.0M
Free Cash FlowOCF − Capex
$25.0K
$8.0M
FCF MarginFCF / Revenue
0.1%
17.0%
Capex IntensityCapex / Revenue
5.6%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-16.8M
$29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFCR
LFCR
TLS
TLS
Q4 25
$8.0M
Q3 25
$1.8M
$9.1M
Q2 25
$7.0M
Q1 25
$1.2M
$6.1M
Q4 24
$-6.1M
$-10.5M
Q3 24
$-613.0K
$-7.1M
Q2 24
$-8.0M
Q1 24
$-1.4M
$-350.0K
Free Cash Flow
LFCR
LFCR
TLS
TLS
Q4 25
$8.0M
Q3 25
$25.0K
$8.7M
Q2 25
$6.8M
Q1 25
$-4.3M
$6.0M
Q4 24
$-8.6M
$-12.4M
Q3 24
$-4.0M
$-7.1M
Q2 24
$-8.2M
Q1 24
$-7.8M
$-447.0K
FCF Margin
LFCR
LFCR
TLS
TLS
Q4 25
17.0%
Q3 25
0.1%
16.9%
Q2 25
19.0%
Q1 25
-12.1%
19.5%
Q4 24
-26.3%
-47.0%
Q3 24
-16.3%
-30.0%
Q2 24
-28.9%
Q1 24
-21.8%
-1.5%
Capex Intensity
LFCR
LFCR
TLS
TLS
Q4 25
0.1%
Q3 25
5.6%
0.9%
Q2 25
0.4%
Q1 25
15.5%
0.4%
Q4 24
7.5%
7.1%
Q3 24
13.9%
0.2%
Q2 24
0.8%
Q1 24
17.8%
0.3%
Cash Conversion
LFCR
LFCR
TLS
TLS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

TLS
TLS

Security Solutions Segment$44.8M96%
Secure Networks Segment$1.9M4%

Related Comparisons